Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$640K Hold
2,000
0.08% 131
2018
Q4
$567K Hold
2,000
0.08% 132
2018
Q3
$639K Hold
2,000
0.07% 138
2018
Q2
$644K Hold
2,000
0.07% 129
2018
Q1
$546K Hold
2,000
0.06% 155
2017
Q4
$486K Hold
2,000
0.05% 168
2017
Q3
$404K Hold
2,000
0.05% 175
2017
Q2
$409K Hold
2,000
0.05% 185
2017
Q1
$365K Hold
2,000
0.05% 223
2016
Q4
$321K Hold
2,000
0.04% 232
2016
Q3
$282K Hold
2,000
0.04% 232
2016
Q2
$273K Hold
2,000
0.04% 214
2016
Q1
$271K Hold
2,000
0.04% 205
2015
Q4
$300K Hold
2,000
0.08% 164
2015
Q3
$267K Hold
2,000
0.08% 167
2015
Q2
$262K Hold
2,000
0.07% 179
2015
Q1
$239K Hold
2,000
0.07% 188
2014
Q4
$211K Hold
2,000
0.06% 188
2014
Q3
$206K Buy
+2,000
New +$203K 0.06% 193

Other funds holding CHE

AT Bancorp's CHE Position: Q1 2019 in Review

AT Bancorp held its Chemed (CHE) position steady in Q1 2019 at 2,000 shares worth $640K. The position accounts for 0.08% of the portfolio, ranked #131.

AT Bancorp first reported a position in CHE in Q3 2014 and has held it in 19 quarters since. The position peaked at $644K in Q2 2018. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

  • AT Bancorp held 2,000 shares of Chemed worth $640K as of Q1 2019.
  • AT Bancorp left its Chemed share count unchanged in Q1 2019.
  • Chemed made up 0.08% of AT Bancorp's portfolio in Q1 2019, its #131 holding.
  • AT Bancorp first reported a position in Chemed in Q3 2014 and has held it in 19 quarters since.
  • AT Bancorp's Chemed position peaked at $644K in Q2 2018.
  • 382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.